11-31801560-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001368894.2(PAX6):c.399+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001368894.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAX6 | NM_001368894.2 | c.399+1G>A | splice_donor_variant, intron_variant | Intron 7 of 13 | ENST00000640368.2 | NP_001355823.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:4
- -
- -
- -
RNA studies determined that this variant results in the loss of 36 residues that are within the paired domain (Hanson et al., 1993; Axton et al., 1997; Chao et al., 2003); Canonical splice site variant predicted to result in an in-frame deletion of a part of the paired domain; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 16712695, 9138149, 8364574, 19218613, 26661695, 25525159, 10234503, 23761016, 12552561, 32360764) -
Aniridia 1 Pathogenic:3
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function. Multiple pathogenic loss-of-function variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000092758 /PMID: 8364574). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
PVS1, PM2, PP3, PP5 -
Aniridia 1;C0344559:Irido-corneo-trabecular dysgenesis Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 92758). Disruption of this splice site has been observed in individual(s) with aniridia (PMID: 8364574, 26661695). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 6 of the PAX6 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PAX6 are known to be pathogenic (PMID: 12634864). -
PAX6-related disorder Pathogenic:1
The PAX6 c.399+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported as causative for aniridia and in some cases was found to arise de novo (Figure 3b in Hanson et al. 1993. PubMed ID: 8364574; reported as c.357+1G>A in Cross et al. 2020. PubMed ID: 32360764; Table S1 in Kit et al. 2021. PubMed ID: 34101622). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Variants that disrupt the consensus splice donor site in PAX6 are expected to be pathogenic, and this variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/92758). Given all the evidence, we interpret c.399+1G>A as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at